THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
批准号:
8328321
负责人:
Vilmundur Gudnason
金额:
$109.04万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-18 至 2012-08-31
关键词:
AcousticsAgeAgreementAirAudiometryBilateralChildCollaborationsConfidentialityDataData CollectionDistantDizzinessDocumentationEarEar DiseasesEnvironmentEpidemiologyEquilibriumEvaluationFirst Degree RelativeFrequenciesFundingGeneticGenetic Predisposition to DiseaseGenome ScanGenotypeHearingHearing AidsHuman ResourcesIcelandInterviewInvestigationIpsilateralKnowledgeLightheadednessMeasuresNational Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institute on Deafness and Other Communication DisordersOtoscopyParentsParticipantPhenotypePoliciesPredispositionPresbycusisPresyncopesPreventionPrivacyProtocols documentationPublicationsQuestionnairesReportingSecond Degree RelativeSiblingsSusceptibility GeneSymptomsSyncopeTinnitusTrainingTympanometryUnited States National Institutes of HealthVertigoWorkacoustic reflexagedaging genebasecohortexperiencefallsfollow-upgene environment interactionhealthy aginghearing impairmentmeetingsoperation
中文摘要
NIDCD项目描述:ags −;Reykjavik研究正在研究遗传易感性和基因/环境相互作用,因为这些因素会导致老年人常见的表型,包括听力损失。NIDCD为本研究提供的听力成分和平衡问卷将支持听力学检查,包括耳镜检查、声阻抗(双侧鼓室测量和同侧声反射)和纯音、空气传导听力学,以确定每只耳朵在500、1000、2000、3000、4000、6000和8000hz时的听力阈值。通过与国家老龄研究所(NIA)之前的机构内协议,2001年至2006年,NIDCD在冰岛雷克雅未克资助了约5200名年龄在67至93岁之间的受试者的听力测试,年龄,基因/环境易感性研究(ages# 8722;Reykjavik I)。D6在目前的AGES - Reykjavik II, NIA和共同发起的ic (NIDCD, NEI和NINDS)正在资助纵向随访检查。在NIDCD的资助下,将询问有关助听器的使用、听力灵敏度的主观评估(包括加劳德特量表)、耳鸣(频率和持续时间)、耳部疾病和手术以及与听力相关的其他因素的问题。还将询问研究参与者经历过(自age I以来)或目前正在经历的特定头晕/平衡和跌倒问题。为了检查广泛的遗传影响,将在现有的AGES数据中确定一级亲属(即兄弟姐妹和亲子组合)。二级亲属或更远的表兄妹也会被识别出来。听力损失遗传学的进一步研究将通过参与广泛的基因组扫描来完成,以确定与特定表型的关联,包括基于AGES I结果定义的与年龄相关的听力损失。
英文摘要
NIDCD Project Description: The AGES−Reykjavik Study is examining genetic susceptibility and gene/environment interaction as these contribute to phenotypes common in old age, including hearing loss. The NIDCD funding of the hearing component and balance questionnaires for this study will support audiometric examinations consisting of otoscopy, acoustic immittance (bilateral tympanometry and ipsilateral acoustic reflexes), and pure-tone, air-conduction audiometry to determine hearing thresholds in each ear at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz. Through a prior IntraAgency Agreement with the National Institute on Aging (NIA), NIDCD funded hearing exams on about 5,200 subjects, aged 67 to 93 years in the Age, Gene/Environment Susceptibility Study−Reykjavik (AGES−Reykjavik I) in Reykjavik, Iceland from 2001 through 2006. D6 In the present AGES¿Reykjavik II, NIA and co-sponsoring ICs (NIDCD, NEI, and NINDS) are funding longitudinal follow-up exams. With NIDCD funding, questions will be asked about use of hearing aids, subjective evaluation of hearing acuity including the Gallaudet scale, tinnitus (frequency and duration), ear diseases and operations, and other factors related to hearing. Questions will also be asked about specific dizziness/balance and falling problems that study participants have experienced (since AGES I) or are experiencing currently. In order to examine broad genetic effects, first-degree relatives will be identified in the existing AGES data (i.e., siblings and parent-child combinations). Second-degree relatives or more distant cousins will also be identified. Further investigation of the genetics of hearing loss will be accomplished through participation in a broad genome scan for associations with defined phenotypes, including age-related hearing loss defined on the basis of results in AGES I.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
-
批准号:10049426
-
项目类别:
-
资助金额:$71.29万
-
财政年份:2021
-
负责人:Vilmundur Gudnason
-
依托单位:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
-
批准号:10390278
-
项目类别:
-
资助金额:$70.45万
-
财政年份:2021
-
负责人:Vilmundur Gudnason
-
依托单位:
THE PURPOSE OF MODIFICATION TO(1)INCREASE EFFORT OF OPTION 2 AND OPTION 3 FOR IC
-
批准号:8366511
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2011
-
负责人:Vilmundur Gudnason
-
依托单位:
THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
-
批准号:8328320
-
项目类别:
-
资助金额:$198.86万
-
财政年份:2011
-
负责人:Vilmundur Gudnason
-
依托单位:
THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
-
批准号:8429081
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2001
-
负责人:Vilmundur Gudnason
-
依托单位:
THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
-
批准号:8429080
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2001
-
负责人:Vilmundur Gudnason
-
依托单位:
THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
-
批准号:7940078
-
项目类别:
-
资助金额:$198.86万
-
财政年份:2001
-
负责人:Vilmundur Gudnason
-
依托单位:
THE AGES STUDY - THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENUM
-
批准号:7940079
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2001
-
负责人:Vilmundur Gudnason
-
依托单位:
AGES STUDY-THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENNIUM
-
批准号:7543844
-
项目类别:
-
资助金额:$813.76万
-
财政年份:2001
-
负责人:Vilmundur Gudnason
-
依托单位:--
THE PURPOSE OF MODIFICATION TO(1)INCREASE EFFORT OF OPTION 2 AND OPTION 3 FOR IC
-
批准号:8429082
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2001
-
负责人:Vilmundur Gudnason
-
依托单位:
AGES STUDY-THE REYKJAVIK STUDY OF HEALTHY AGING FOR THE NEW MILLENNIUM-26012100
-
批准号:6994609
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Vilmundur Gudnason
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: